|
|
VR2210 DNA vaccine plasmid |
|
DNA Vaccine Plasmid ID |
109 |
|
DNA Vaccine Plasmid Name |
VR2210 DNA vaccine plasmid |
|
Plasmid VO ID |
VO_0005023
|
|
Promoter Names |
CMV |
|
Antibiotics Resistant Gene |
kanamycin |
|
Plasmid Description |
Constructed by the molecular ligation of three purified DNA fragments: PstI/XbaI-digested VR1012 plasmid DNA; PstI/KpnI-digested DNA fragment from the human tissue plasminogen activator (hTPA) gene, including a portion (113 bp) of the 5 ' -untranslated region proximal to and including the leader peptide (aa 1-23); and KpnI/XbaI-digested DNA encoding aa 17- 273 of the B31 ospA gene (Luke et al., 1997) |
| Related Vaccine(s) |
|
| References |
Luke et al., 1997: Luke CJ, Carner K, Liang X, Barbour AG. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi. The Journal of infectious diseases. 1997; 175(1); 91-97. [PubMed: 8985201].
|
|
